✦ LIBER ✦

Induction of HIV-1 Gag-specific memory T cells in Chacma baboons by MVA prime and VLP boost vaccine regimen

✍ Scribed by V Singh, G Chege, E Shephard, A Williamson

Book ID: 120691338
Publisher: BioMed Central
Year: 2012
Tongue: English
Weight: 74 KB
Volume: 9
Category: Article
ISSN: 1742-4690
DOI: 10.1186/1742-4690-9-S2-P27

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Breadth, phenotype and functionality of

Breadth, phenotype and functionality of Gag-specific T cell responses induced by a heterologous DNA/MVA prime-boost HIV-1 vaccine regimen

✍ L Podola, A Bauer, A Haule, L Sudi, C Nilsson, K Godoy-Ramirez, P Mann… 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 66 KB

Induction of long-lasting multi-specific

Induction of long-lasting multi-specific CD8+ T cells by a four-component DNA-MVA/HIVA-RENTA candidate HIV-1 vaccine in rhesus macaques

✍ Eung-Jun Im; Joseph P. Nkolola; Kati di Gleria; Andrew J. McMichael; Tomáš Hanke 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 613 KB

## Abstract As a part of a long‐term effort to develop vaccine against HIV‐1 clade A inducing protective T cell responses in humans, we run mutually complementing studies in humans and non‐human primates (NHP) with the aim to maximize vaccine immunogenicity. The candidate vaccine under development

Studies on the cross-clade and cross-spe

Studies on the cross-clade and cross-species conservation of HIV-1 Gag-specific CD8 and CD4 T cell responses elicited by a clade B DNA/MVA vaccine in macaques

✍ Rama Rao Amara; Sunita Sharma; Milloni Patel; James M. Smith; Lakshmi Chennaredd 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 542 KB

Lessons from IAVI-006, a Phase I clinica

Lessons from IAVI-006, a Phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to induce HIV-1 specific T-cell responses in healthy volunteers

✍ A. Guimarães-Walker; N. Mackie; S. McCormack; T. Hanke; C. Schmidt; J. Gilmour; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 498 KB

Corrigendum to “Lessons from IAVI-006, a

Corrigendum to “Lessons from IAVI-006, a Phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to induce HIV-1 specific T-cell responses in healthy volunteers” [Vaccine 26 (2008) 6671–6677]

✍ A. Guimarães-Walker; N. Mackie; S. McCormack; T. Hanke; C. Schmidt; J. Gilmour; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 91 KB